APCO WORLDWIDE LLC for HIKMA PHARMACEUTICALS USA INC.
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Health and pharmaceutical policies and domestic pharmaceutical manufacturing supply chain issues and drug shortage issues
Foreign entity interest: Hikma Pharmaceuticals PLC, identified in the LD-1, has an indirect interest in U.S. policy relating to health and pharmaceutical products.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MIKASA MODI | — |
| ALLISON PARKER-LAGOO | Assistant to the Chief of Staff, Sen. Hagan |
| DAN SCANDLING | Chief of Staff & Press Secretary, Rep. Bateman |
Trade (domestic/foreign) TRD
Trade policies impacting domestic generic pharmaceutical manufacturing
Foreign entity interest: Hikma Pharmaceuticals PLC, identified in the LD-1, has an indirect interest in U.S. policy relating to health and pharmaceutical products.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MIKASA MODI | — |
| ALLISON PARKER-LAGOO | Assistant to the Chief of Staff, Sen. Hagan |
| DAN SCANDLING | Chief of Staff & Press Secretary, Rep. Bateman |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.